Al Razi Medical Company

Al Razi Medical Company

TTADAWUL:9572
25.30
SAR
-0.66
(-2.54%)
48.49MMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
34.47
40.35
40.36
48.94
- -
Basic EPS, GAAP
1.33
0.45
0.12
0.54
- -
Free Cash Flow per Basic Share
1.35
0.47
0.72
2.53
- -
Dividend per Share
- -
1.59
- -
- -
- -
Book Value per Share
15.52
14.72
14.88
15.46
15.74
Tangible Book Value per Share
15.35
14.4
14.66
15.33
15.64
Basic Weighted Avg Shares
2
2
2
2
2
Sales/Revenue/Turnover
52
61
61
74
- -
Operating Margin (%)
5.55
2.82
1.34
2.65
- -
Depreciation Expense
3
4
4
4
- -
Net Income, GAAP
2
1
- -
1
- -
Effective Tax Rate (%)
16.94
36.82
66.8
23.31
- -
Profit Margin (%)
3.84
1.12
0.29
1.1
- -
Working Capital
14
11
11
9
9
LT Debt
6
8
6
9
8
Total Equity
24
22
23
24
24
Return on Invested Capital (%)
- -
2.73
0.44
3.59
- -
Return on Capital (%)
- -
3.07
1.07
4.35
- -
Return on Common Equity (%)
- -
2.98
0.78
3.55
- -

Capital Structure

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
4
3
3
LT Borrowings
2
1
- -
LT Finance Leases
8
8
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
60
46
48

Working Capital

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
26
29
26
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
5
4
3
Inventories
20
24
21
Total Current Liabilities
16
20
16
Payables & Accruals
- -
- -
- -
ST Debt
4
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
3.89%
Free Cash Flow
- -
- -
252.65%
Net Income, GAAP
- -
- -
365.96%
Sales/Revenue/Turnover
- -
- -
21.24%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
61
2025
- -
- -
74
2026
- -
- -
- -

Semi-annual Earnings Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.12
2025
- -
- -
0.54
2026
- -
- -
- -

Semi-annual Dividends Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Hassan Dawoud Mohamed
Full Time Employees
123
Sector
Retail trade
Industry
Drugstore chains
Address
King Abdul Aziz Road Al-Bada'ea QA Saudi Arabia 31432
IPO Date
Jun 22, 2023
Website
razi.sa
Business
Al-Razi Medical Company Al-Razi Medical Company SJSC (9572.SR) is a Saudi Arabia-based healthcare distributor that specializes in supplying medical equipment, supplies, and related products to hospitals, clinics, medical centers, medical companies, and pharmacies. Founded in 1986 and headquartered in Dammam with operations across the Eastern, Central, Western, and Southern regions of the Kingdom through five branches, the company stores, sells, and markets a wide range of items including hospital beds; steam and suction devices; inhalation devices; masks; needles; oxygen masks; water bladders; bandages; gloves; and consumer healthcare products such as personal care, skin care, hair care, makeup, and accessories. Its primary customer base encompasses government and private healthcare institutions, with all sales concentrated in Saudi Arabia and recent revenue reaching approximately SAR 61.33 million in fiscal year 2023. In recent developments, Al-Razi Medical Company secured Islamic credit facilities from Al Rajhi Bank, including a SAR 3 million facility, and underwent board changes with the appointment of Abdulmajeed bin Abdulrahman Al-Arini as an independent board member at its extraordinary general meeting in May 2025; the company also reported lower net profit for fiscal year 2024 despite revenue growth and maintains a focus on expanding its distribution network in the medical equipment wholesale sector.